Collegium Pharmaceutical Director Gino Santini Exercises Stock Options and Acquires Shares

Gino Santini, a director of Collegium Pharmaceutical, Inc. (COLL), exercised 8,700 stock options on June 8, 2026, at an exercise price of $16.49 per share. The options, which were fully vested and exercisable, expired on June 9, 2026. Following the exercise, Santini acquired 8,700 shares of common stock at the same price of $16.49 per share. This transaction increased his total direct holdings to 112,483 shares. The filing represents a routine option exercise by a company director ahead of the options' expiration, resulting in the acquisition of additional equity in the company.